Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | GAA | P10253 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | S100B | P04271 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1706988 | 0.90 | GAA (0.58) | POLBL3MBTL1ALDH1A1GAACYP3A4 | |
| SCHEMBL5951914 | 0.87 | ALDH1A1 (0.48) | POLBL3MBTL1ALDH1A1GAACYP3A4 | |
| SCHEMBL8080817 | 0.87 | L3MBTL1 (0.56) | POLBL3MBTL1ALDH1A1GAACYP3A4 | |
| SCHEMBL926329 | 0.87 | L3MBTL1 (0.67) | POLBL3MBTL1ALDH1A1GAACYP3A4 | |
| SCHEMBL10256995 | 0.85 | CYP3A4 (0.55) | POLBL3MBTL1ALDH1A1GAACYP3A4 | |
| SCHEMBL9520839 | 0.85 | L3MBTL1 (0.60) | POLBL3MBTL1ALDH1A1GAACYP3A4 | |
| SCHEMBL453847 | 0.85 | L3MBTL1 (0.60) | POLBL3MBTL1ALDH1A1GAACYP3A4 | |
| SCHEMBL6314009 | 0.85 | POLB (0.59) | POLBL3MBTL1ALDH1A1GAACYP3A4 | |
| SCHEMBL30723004 | 0.85 | L3MBTL1 (0.60) | POLBL3MBTL1ALDH1A1GAACYP3A4 | |
| SCHEMBL29540409 | 0.85 | L3MBTL1 (0.60) | POLBL3MBTL1ALDH1A1GAACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114965780-B | Method for simultaneously measuring 30 mental active substances in environmental water body | 中科检测技术服务(广州)股份有限公司 | 2024-09-24 | — | — | CN | claimed |
| EP-4276224-A1 | FUNCTIONNALISED COPPER ELECTROCHEMICAL CATALYSTS FOR CONVERSION OF CO2 TO SMALL MOLECULES | Centre national de la recherche scientifique (FR) | 2023-11-15 | — | — | EP | disclosed |
| EP-2588144-B1 | DETECTING TARGETS USING MASS TAGS AND MASS SPECTROMETRY | VENTANA MED SYST INC (US) | 2018-05-09 | — | — | EP | disclosed |
| US-9791399-B2 | Derivatization of carbon | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2017-10-17 | — | — | US | disclosed |
| US-20140332412-A1 | DERIVATIZATION OF CARBON | SCHLUMBERGER TECHNOLOGY COPORATION (US) | 2014-11-13 | — | — | US | disclosed |
| US-20120142667-A1 | PYRIMIDINE DERIVATIVES AS ZAP-70 INHIBITORS | CELLZOME LIMITED (GB) | 2012-06-07 | — | — | US | disclosed |
| EP-2440534-A2 | PYRIMIDINE DERIVATIVES AS ZAP-70 INHIBITORS | Cellzome Limited (GB) | 2012-04-18 | — | — | EP | disclosed |
| WO-2010142766-A2 | PYRIMIDINE DERIVATIVES AS ZAP-70 INHIBITORS | CELLZOME LIMITED (GB) | 2010-12-16 | — | — | WO | disclosed |
| US-5731340-A | DIETETICS; ANTIDIABETIC AGENTS | SANOFI (FR) | 1998-03-24 | — | — | US | disclosed |
| CN-1131144-A | Glycinamide derivatives, processes for their preparation and medicines containing them | SANOFI SA (FR) | 1996-09-18 | — | — | CN | disclosed |
| EP-0697403-A1 | Derivatives of glycinamides as cholecystokinin receptor agonists | SANOFI (FR) | 1996-02-21 | — | — | EP | disclosed |
| US-4163059-A | Pesticidally active 4,5-dichloro-3-substituted-phenylimino-1,2-dithiolenes | BAYER AKTIENGESELLSCHAFT (DE) | 1979-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142667-A1 | PYRIMIDINE DERIVATIVES AS ZAP-70 INHIBITORS | ZAP70, LCK, DPY30 | POLB 741/4885L3MBTL1 2852/4885ALDH1A1 3057/4885 |
| US-20140332412-A1 | DERIVATIZATION OF CARBON | FTH1, CBR1, SDHB | POLB 4228/4885L3MBTL1 4486/4885ALDH1A1 162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.